Stereotaxis, Inc. (STXS): Company Cash Volume

Official company branding of Stereotaxis Corp (STXS)

The implementation of sustainable production standards positively impacts the cash balance, whose historical trend on the GURU.Markets chart confirms stability. 0.00 indicates the current liquidity level. The financial base of Stereotaxis, Inc. (STXS) relies on stable service contracts and the low cyclicality of cardiac surgery. Business growth is driven by innovative Genesis systems, where AI manipulators provide precision control of catheters.

Company Cash Funds: Stereotaxis Corporation (STXS) for 07/04/2022 - 11/21/2026

Summary analytical data breakdowns for Stereotaxis Inc (STXS)

- stock quotes and analyst forecast:
Initial company analysis:Stereotaxis Corporation STXS
Brand item of Stereotaxis

This indicator measures the volume of liquid assets, determining the issuer's ability to cover short-term liabilities without selling fixed assets. For Stereotaxis, Inc. (STXS), with its narrow specialization in robotic cardiac surgery, a sufficient cash reserve is critical for maintaining costly IT developments. By analyzing the company's cash dynamics, an investor assesses the business's resilience to limited sales risks. A stable liquidity level confirms solvency, minimizing the probability of capital degradation.

Analysis of competing companies

Company Cash Volume BSX|Company Cash Funds EW (Edwards Lifesciences Corporation)|Company Cash Funds ResMed RMD|Company Cash Volume Insulet Corp PODD|ZBH: Company Cash on Hand|Company Cash Balance COO (CooperVision)|ALGN (Align Technology, Inc.) - Company Cash on Hand|Globus Medical, Inc. - Company Cash Balance|TMDX (TransMedics Group Inc) - Company Cash Volume|Company Cash Reserve Alphatec Holdings ATEC|Company Cash Funds CryoLife (AORT)|Enovis Corporation (ENOV) - Company Cash Position|Integra LifeSciences Inc. - Company Cash on Hand|Company Cash Volume Establishment Labs ESTA|Beta Bionics, Inc. - Company Cash Volume|Company Liquid Assets IRADIMED Corp IRMD|Embecta (EMBC) - Company Cash Funds|Company Total Cash Volume TNDM (Tandem Corp)|Company Cash Funds axogeninc.com|Company Cash on Hand SI-BONE, Inc. (SIBN)|Company Cash Volume OFIX|Bioventus Corp - Company Cash and Cash Equivalents|Company Cash Funds orthopediatrics.com KIDS|TMCI: Company Cash and Cash Equivalents|SRTA: Company Cash on Hand|Carlsmed Inc - Company Total Cash Amount|RxSight (RXST) - Company Cash Funds|Company Cash on Hand ClearPoint|STIM (neurostar.com) - Company Cash Volume|Sight Sciences, Inc (SGHT) - Company Liquid Assets|Company Cash Volume OBIO|Company Liquid Assets Anika Therapeutics Inc.|Company Cash Funds InspireMD, Inc. NSPR|Company Cash Balance ZJYL|VANI - Company Cash Funds|Xtant Medical Holdings, Inc. - Company Total Cash Amount|NeuroOne (NMTC) - Company Cash Funds|Modular Med (MODD) - Company Cash Volume|Company Cash Funds Myomo, Inc|Company Cash on Hand Envoy Medical (COCH)|Company Cash Volume VVOS|NVNO (enVVeno Corp) - Company Cash Balance|Company Cash Volume SINT (Sintx Technologies)|TNON: Company Cash and Cash Equivalents|Lifeward - Company Cash Volume|Company Cash Balance AMIX (Autonomix Medical)|IVF: Company Cash Volume|Company Cash Position Bone Biologics Corporation BBLG|Company Cash on Hand AXNX|BIOLASE, Inc. (BIOL) - Company Liquid Assets|Company Cash Volume DYNT|Company Liquid Assets Paragon 28|Company Cash Volume INVO (INVO Bioscience, Inc.)